Topics
October 2016 | business Of Retinainnovations In Retina
Visual Function Biomarkers Needed for Dry AMD
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.
Aron Shapiro
March 2016 | business Of Retinainnovations In Retina
Ocular Gene Therapy Trials Advance
Results of the first phase 3 trial were announced.
October 12, 2026
ANI Pharmaceuticals Reports Sustained 24-Month Efficacy of Iluvien in Phase 4 SYNCHRONICITY trial
Merck’s Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME
American Academy of Ophthalmology Announces 2026 Award Recipients at Annual Conference
Brent Saunders Departs as CEO of Bausch + Lomb
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
